Current:Home > ContactWhy does Ozempic cost so much? Senators grilled Novo Nordisk CEO for answers. -PrestigeTrade
Why does Ozempic cost so much? Senators grilled Novo Nordisk CEO for answers.
View
Date:2025-04-15 15:32:21
Senators grilled the top executive of Novo Nordisk over why the Danish company charges Americans far more for the blockbuster weight-loss drug Wegovy and diabetes drug Ozempic than it does patients in Europe.
Novo Nordisk CEO Lars Fruergaard Jørgensen appeared before the Senate Committee on Health, Education, Labor and Pensions. The committee is chaired by Sen. Bernie Sanders, a Vermont independent who launched an investigation this year into Novo Nordisk's drug pricing.
Novo Nordisk has made nearly $50 billion on the sales of Ozempic and Wegovy since 2018, Sanders said. He described the U.S. as a "cash cow" for Novo Nordisk, accounting for 72% of the company's worldwide sales of those two drugs.
Among questions posed by Sanders: Why do Americans pay far more for these medications than patients in other countries?
Sanders opened the hearing by displaying charts comparing Novo Nordisk's prices charged to Americans and Europeans. The company charges U.S. residents $969 a month for Ozempic, but the same drug costs $155 in Canada, $122 in Denmark, and $59 in Germany.
For the weight-loss drug Wegovy, Americans pay $1,349 a month. The drug can be purchased for $186 in Denmark, $140 in Germany, and $92 in the United Kingdom, according to Sanders' charts.
"Nobody here is asking Novo Nordisk to provide charity to the American people," Sanders said. "All we are saying, Mr. Jørgensen, is treat the American people the same way that you treat people all over the world. Stop ripping us off."
Jørgensen defended the company's pricing of the wildly popular medications and said 80% of Americans can get these drugs for $25 or less per month.
He said U.S. list prices can't be compared to prices charged in other countries, in part, due to the nation's complex structure. U.S. prices are influenced by health insurance companies and drug-pricing middlemen called pharmacy benefit managers.
Jørgensen said the diabetes drug Ozempic is covered by the vast majority of private health insurance plans, as well as Medicare and Medicaid, the government health insurance programs for seniors and low-income families. Wegovy is covered by about half of private health insurers, Medicaid plans in 20 states and the Department of Veterans Affairs.
"You have said that our amazing medicines can't help patients if they can't afford them ‒ that is true," Jørgensen said. "It is also true that the full value of Ozempic and Wegovy can only be realized if patients can access them. Patients need affordability and access."
Medicare, the federal health program for adults 65 and older, is prohibited by law from covering drugs for those who are obese but otherwise do not have serious risk factors. But obese patients with diabetes or heart disease may qualify for coverage. The nonprofit health policy organization KFF estimated that 1 in 4 Medicare enrollees who are obese may be eligible for Wegovy to reduce their risk of heart attack or stroke.
The committee also highlighted a March study from researchers at Yale University found these drugs could be made for less than $5 a month, or $57 per year. Last week, Sanders announced CEOs of major generic pharmaceutical companies would be willing to sell Ozempic to Americans for less than $100 per month, at a profit. However, such estimates do not account for the expensive costs of researching and developing drugs and testing them in clinical trials.
Jørgensen said Novo Nordisk scientists have worked on the weight-loss drugs since the early 1990s. The company also has committed $30 billion to expand manufacturing capacity to address supply shortages of the medications.
Representatives of drug industry's trade group PhRMA said health insurers and pharmacy benefit managers deserve more scrutiny when it comes to drug affordability.
“The one question everyone should be asking is why aren’t insurers and PBMs being forced to answer for denying coverage and driving up patients’ costs?" said Alex Schriver, senior vice president of public affairs at PhRMA: "Senator Sanders continues repeating the same misleading rhetoric on drug prices. But why won’t he talk about how insurance conglomerates are taking in record profits or how PBMs are being investigated and sued for their abusive tactics?"
veryGood! (4628)
Related
- Current, future North Carolina governor’s challenge of power
- The doctor who warned the world of the mpox outbreak of 2022 is still worried
- The Best Memorial Day Sales 2023: Sephora, Nordstrom Rack, Wayfair, Kate Spade, Coach, J.Crew, and More
- More brides turning to secondhand dresses as inflation drives up wedding costs
- Intellectuals vs. The Internet
- FDA warns stores to stop selling Elf Bar, the top disposable e-cigarette in the U.S.
- Hepatitis C can be cured. So why aren't more people getting treatment?
- Kim Kardashian Reveals the Meaningful Present She Gives Her 4 Kids Each Year on Their Birthdays
- Meta releases AI model to enhance Metaverse experience
- More brides turning to secondhand dresses as inflation drives up wedding costs
Ranking
- Questlove charts 50 years of SNL musical hits (and misses)
- American Climate Video: On a Normal-Seeming Morning, the Fire Suddenly at Their Doorstep
- Lawyers fined for filing bogus case law created by ChatGPT
- A step-by-step guide to finding a therapist
- Bill Belichick's salary at North Carolina: School releases football coach's contract details
- These kids revamped their schoolyard. It could be a model to make cities healthier
- Oil Pipelines or Climate Action? Trudeau Walks a Political Tightrope in Canada
- The NCAA looks to weed out marijuana from its banned drug list
Recommendation
Bill Belichick's salary at North Carolina: School releases football coach's contract details
American Climate Video: Al Cathey Had Seen Hurricanes, but Nothing Like Michael
Taylor Swift's Reaction to Keke Palmer's Karma Shout-Out Is a Vibe Like That
How Jessica Biel Helped the Cruel Summer Cast Capture the Show’s Y2K Setting
Justice Department, Louisville reach deal after probe prompted by Breonna Taylor killing
Miles Teller and Wife Keleigh Have a Gorgeous Date Night at Taylor Swift's Concert
Zayn Malik Sends Heartfelt Message to Fans in Rare Social Media Return
Massachusetts’ Ambitious Clean Energy Bill Jolts Offshore Wind Prospects